Ryman Healthcare Limited Ordinary Shares
RYM.NZXHealth Care
Ryman Healthcare limited (RYM) is the largest provider of retirement living options for New Zealanders over the age of 70. The company provides a range of retirement living and care options, including independent townhouses and apartments, serviced apartments and care centres providing resthome, dementia and hospital-level care. RYM was established in Christchurch in 1984. It was listed in June 1999 followed a public offering of 30 million shares at a price of $1.35. In January 2007 the company implemented a 5:1 share split. In 2014 RYM opened its first village in Melbourne and plans to build four more in Victoria by 2020. As at July 2016, RYMs 30 retirement villages in New Zealand and Australia provided homes for over 10,000 residents and employed more than 4,000 staff.
Market Data
$2.300
+0.0%$2.3B
-13.6x
$-0.169
0.00%
+0.1%
Recent Announcements
RYM exchange mechanism of RYM010 bonds for RYM020 bonds
Ryman Healthcare Limited (RYM) is offering up to NZ$100 million in new RYM020 bonds (with capacity for an additional NZ$50 million) to New Zealand and institutional investors, with an exchange mechanism allowing holders of existing RYM010 bonds held through custodial accounts to exchange them one-for-one for RYM020 bonds at NZ$1.00 face value on the issue date of 22 June 2026.
Ryman launches fixed rate retail bond offer
Ryman Healthcare Limited is launching an offer of up to NZ$100 million in fixed-rate, secured bonds maturing in 2032, with an indicative issue margin of 1.80-1.90% over swap rate and a minimum interest rate of 5.60% per annum; existing RYM010 bondholder can exchange their bonds on a one-for-one basis under specified conditions.
Ongoing Disclosure Notice – Hamish Rumbold
Hamish John Rumbold, a Director of Ryman Healthcare Limited, acquired 26,238 ordinary shares (RYM) on 4 June 2026 through an on-market purchase at $2.2750 per share for a total consideration of $59,691.45, increasing his holding from 0 to 26,238 shares.
Annual report and corporate governance statement
Ryman Healthcare delivered a strong FY26 result, with Operating EBITDAF nearly doubling to NZ$88.3M (+94% vs FY25) and the company generating positive free cash flow of $188.3M for the first time in over a decade (vs -$94.2M in FY25). The business completed its balance sheet reset with $600M+ in available debt headroom and no bank maturities until FY31, while delivering $57M in annualised cost savings over two years. Management outlined a clear pathway to return to dividends in FY28, with a payout policy of 20-50% of cash flow from existing operations per share. Key points: Operating EBITDAF (non-GAAP) almost doubled to $88.3M (+94% vs FY25 $45.5M), reflecting material improvement in operating profitability; Free cash flow turned strongly positive at $188.3M vs -$94.2M in FY25, the first positive free cash flow in over a decade; Annualised cost savings of $57M delivered over two financial years, with $47M sustainable improvement in cash flow from existing operations in FY26
Closing date for director nominations
Ryman Healthcare Limited announced that director Paula Jeffs will not seek re-election at the 2026 Annual Shareholder Meeting on 28 July 2026, while directors Dean Hamilton, James Miller, and Hamish Rumbold will retire in accordance with the constitution and intend to stand for re-election. The closing date for director nominations is 22 June 2026 at 5:00 pm (New Zealand time).
Ongoing Disclosure Notice – James Miller
James Bruce Miller, a director of Ryman Healthcare Limited, acquired 8,800 ordinary shares on 2 June 2026 through an on-market purchase at $2.26 per share for $19,888, increasing his beneficial holding from 35,000 to 43,800 shares.
Ongoing Disclosure Notice – Naomi James
Naomi Margaret James, CEO of Ryman Healthcare Limited, purchased 96,926 ordinary shares on 2 June 2026 for $219,290.23 (average price $2.26 per share) on-market, increasing her holding from 264,477 to 361,403 shares.
Ongoing Disclosure Notice – Matthew Prior
Matthew Prior, CFO of Ryman Healthcare Limited, acquired 51,000 ordinary shares on 3 June 2026 for $115,652 (at $2.2677 per share) through on-market purchase, increasing his family trust's holding from 70,000 to 121,000 shares.
Ryman considers retail bond offer
Ryman Healthcare Limited is considering an offer of 6-year fixed rate secured bonds to institutional and retail investors in New Zealand, with full details expected in the week of 8 June 2026. Existing RYM010 bondholders with custodial accounts may have the option to exchange their bonds on a one-for-one basis for the new bonds.
Ongoing Disclosure Notice – Dean Hamilton
Dean Ross Hamilton, a Director of Ryman Healthcare Limited, acquired 86,514 ordinary shares (RYM) on 28 May 2026 through an on-market purchase at $2.30 per share for $198,998.46, increasing his holding from 69,838 to 156,352 shares.
Get real-time alerts for RYM
Receive AI-powered earnings summaries and instant notifications when Ryman Healthcare Limited Ordinary Shares releases results.
Register Free